Maria A. Gandini
Affiliations: | University of Calgary, Calgary, Alberta, Canada |
Area:
Calcium ChannelsGoogle:
"Maria Gandini"Mean distance: 17.82 (cluster 11) | S | N | B | C | P |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Gandini MA, Zamponi GW. (2021) Voltage-gated calcium channel nanodomains: molecular composition and function. The Febs Journal |
| Gandini MA, Souza IA, Ferron L, et al. (2021) The de novo CACNA1A pathogenic variant Y1384C associated with hemiplegic migraine, early onset cerebellar atrophy and developmental delay leads to a loss of Cav2.1 channel function. Molecular Brain. 14: 27 |
| Huang M, Nibbeling EAR, Lagrand TJ, et al. (2021) Rare functional missense variants in CACNA1H: What can we learn from Writer's cramp? Molecular Brain. 14: 18 |
| Gambeta E, Gandini MA, Souza IA, et al. (2021) A CACNA1A variant associated with trigeminal neuralgia alters the gating of Cav2.1 channels. Molecular Brain. 14: 4 |
| Ficelova V, Souza IA, Cmarko L, et al. (2020) Functional identification of potential non-canonical N-glycosylation sites within Ca3.2 T-type calcium channels. Molecular Brain. 13: 149 |
| Huang J, Gandini MA, Chen L, et al. (2020) Hyperactivity of Innate Immunity Triggers Pain via TLR2-IL-33-Mediated Neuroimmune Crosstalk. Cell Reports. 33: 108233 |
| Nam Y, Ryu KD, Jang C, et al. (2020) Synthesis and cytotoxic effects of 2-thio-3,4-dihydroquinazoline derivatives as novel T-type calcium channel blockers. Bioorganic & Medicinal Chemistry. 115491 |
| Gandini MA, Souza IA, Raval D, et al. (2019) Differential regulation of Cav2.2 channel exon 37 variants by alternatively spliced μ-opioid receptors. Molecular Brain. 12: 98 |
| Souza IA, Gandini MA, Zhang FX, et al. (2019) Pathogenic Cav3.2 channel mutation in a child with primary generalized epilepsy. Molecular Brain. 12: 86 |
| Aygün Cevher H, Schaller D, Gandini MA, et al. (2019) Discovery of Michael acceptor containing 1,4-dihydropyridines as first covalent inhibitors of L-/T-type calcium channels. Bioorganic Chemistry. 91: 103187 |